TELA

SEC source: 0001192482-19-000434 · edgar.xml · derivative · entry 6

KOBLISH ANTONY · CIK 0001195881 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,775

Underlying: Common Stock · 436 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000434 · edgar.xml · derivative · entry 5

KOBLISH ANTONY · CIK 0001195881 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series B Preferred Stock · 10,775 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000434 · edgar.xml · derivative · entry 4

KOBLISH ANTONY · CIK 0001195881 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,225 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.exercise_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.expiration_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

SEC source: 0001192482-19-000434 · edgar.xml · derivative · entry 3

KOBLISH ANTONY · CIK 0001195881 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,277 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.exercise_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.expiration_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000434 · edgar.xml · nonDerivative · entry 2

KOBLISH ANTONY · CIK 0001195881 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,085

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

SEC source: 0001192482-19-000434 · edgar.xml · nonDerivative · entry 1

KOBLISH ANTONY · CIK 0001195881 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,860

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F2 · balance_after: Reflects 16,273 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a).

SEC source: 0001192482-19-000420 · edgar.xml · derivative · entry 7

Oliva Adele C · CIK 0001339379 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Quaker Bioventures II, L.P.

Disclosed balance after: 446,813

Underlying: Common Stock · 18,096 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise.

SEC source: 0001192482-19-000420 · edgar.xml · derivative · entry 6

Oliva Adele C · CIK 0001339379 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Quaker Bioventures II, L.P.

Disclosed balance after: 0

Underlying: Series B Preferred Stock · 446,813 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise.

SEC source: 0001192482-19-000420 · edgar.xml · derivative · entry 5

Oliva Adele C · CIK 0001339379 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Quaker Bioventures II, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 516,947 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.exercise_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.expiration_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F5 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise.

SEC source: 0001192482-19-000420 · edgar.xml · derivative · entry 4

Oliva Adele C · CIK 0001339379 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Quaker Bioventures II, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 345,489 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.exercise_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.expiration_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F5 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise.

SEC source: 0001192482-19-000420 · edgar.xml · nonDerivative · entry 3

Oliva Adele C · CIK 0001339379 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Quaker Bioventures II, L.P.

Disclosed balance after: 1,751,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise.

SEC source: 0001192482-19-000420 · edgar.xml · nonDerivative · entry 2

Oliva Adele C · CIK 0001339379 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Quaker Bioventures II, L.P.

Disclosed balance after: 1,234,153

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise.

SEC source: 0001192482-19-000432 · edgar.xml · derivative · entry 2

Ellis Ronald J. Jr. · CIK 0001790670 · Director · 10% owner

Pacira BioSciences, Inc. · CIK 0001396814 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pacira BioSciences, Inc.

Disclosed balance after: 0

Underlying: Common Stock · 580,357 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.exercise_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.expiration_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000432 · edgar.xml · nonDerivative · entry 1

Ellis Ronald J. Jr. · CIK 0001790670 · Director · 10% owner

Pacira BioSciences, Inc. · CIK 0001396814 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pacira BioSciences, Inc.

Disclosed balance after: 774,056

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F2 · balance_after: Reflects 193,699 shares of common stock received as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a).

SEC source: 0001192482-19-000425 · edgar.xml · derivative · entry 2

Brennan Nora · CIK 0001790215 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,491 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.exercise_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.expiration_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F2 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000425 · edgar.xml · nonDerivative · entry 1

Brennan Nora · CIK 0001790215 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,668

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F2 · balance_after: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

F3 · balance_after: Reflects 177 shares of common stock received by the reporting person as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a).

SEC source: 0001192482-19-000428 · edgar.xml · derivative · entry 14

Zuga Matt · CIK 0001790214 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners, L.P.

Disclosed balance after: 1,665

Underlying: Common Stock · 67 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000428 · edgar.xml · derivative · entry 13

Zuga Matt · CIK 0001790214 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners, L.P.

Disclosed balance after: 0

Underlying: Series B Preferred Stock · 1,665 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000428 · edgar.xml · derivative · entry 12

Zuga Matt · CIK 0001790214 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners QP, L.P.

Disclosed balance after: 123,653

Underlying: Common Stock · 5,008 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000428 · edgar.xml · derivative · entry 11

Zuga Matt · CIK 0001790214 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners QP, L.P.

Disclosed balance after: 0

Underlying: Series B Preferred Stock · 123,653 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000428 · edgar.xml · derivative · entry 10

Zuga Matt · CIK 0001790214 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 2,931 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.exercise_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.expiration_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F5 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000428 · edgar.xml · derivative · entry 9

Zuga Matt · CIK 0001790214 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners QP, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 217,816 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.exercise_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.expiration_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F5 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000428 · edgar.xml · derivative · entry 8

Zuga Matt · CIK 0001790214 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 269 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.exercise_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.expiration_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F5 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000428 · edgar.xml · derivative · entry 7

Zuga Matt · CIK 0001790214 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners QP, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 19,982 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.exercise_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.expiration_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F5 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000428 · edgar.xml · nonDerivative · entry 6

Zuga Matt · CIK 0001790214 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners QP, L.P.

Disclosed balance after: 498,606

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

SEC source: 0001192482-19-000428 · edgar.xml · nonDerivative · entry 5

Zuga Matt · CIK 0001790214 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners QP, L.P.

Disclosed balance after: 280,790

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

SEC source: 0001192482-19-000428 · edgar.xml · nonDerivative · entry 4

Zuga Matt · CIK 0001790214 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners, L.P.

Disclosed balance after: 15,875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

SEC source: 0001192482-19-000428 · edgar.xml · nonDerivative · entry 3

Zuga Matt · CIK 0001790214 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners, L.P.

Disclosed balance after: 12,944

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

SEC source: 0001192482-19-000421 · edgar.xml · derivative · entry 8

Friedman Ashley · CIK 0001790193 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Signet Healthcare Partners Accredited Partnership III, LP

Disclosed balance after: 148,499

Underlying: Common Stock · 6,014 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000421 · edgar.xml · derivative · entry 7

Friedman Ashley · CIK 0001790193 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Signet Healthcare Partners QP Partnership III, LP

Disclosed balance after: 0

Underlying: Series B Preferred Stock · 148,499 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000421 · edgar.xml · derivative · entry 6

Friedman Ashley · CIK 0001790193 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Signet Healthcare Partners Accredited Partnership III, LP

Disclosed balance after: 31,168

Underlying: Common Stock · 1,262 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000421 · edgar.xml · derivative · entry 5

Friedman Ashley · CIK 0001790193 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Signet Healthcare Partners Accredited Partnership III, LP

Disclosed balance after: 0

Underlying: Series B Preferred Stock · 31,168 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000421 · edgar.xml · derivative · entry 4

Friedman Ashley · CIK 0001790193 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Signet Healthcare Partners QP Partnership III, LP

Disclosed balance after: 0

Underlying: Common Stock · 285,580 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.exercise_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.expiration_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000421 · edgar.xml · derivative · entry 3

Friedman Ashley · CIK 0001790193 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Signet Healthcare Partners Accredited Partnership III, LP

Disclosed balance after: 0

Underlying: Common Stock · 59,940 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.exercise_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.expiration_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000421 · edgar.xml · nonDerivative · entry 2

Friedman Ashley · CIK 0001790193 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Signet Healthcare Partners QP Partnership III, LP

Disclosed balance after: 505,281

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · balance_after: Reflects 219,701 shares of common stock received as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a).

F4 · balance_after: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000421 · edgar.xml · nonDerivative · entry 1

Friedman Ashley · CIK 0001790193 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Signet Healthcare Partners Accredited Partnership III, LP

Disclosed balance after: 106,052

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F2 · balance_after: Reflects 46,112 shares of common stock received as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a).

SEC source: 0001192482-19-000424 · edgar.xml · derivative · entry 14

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners, L.P.

Disclosed balance after: 1,665

Underlying: Common Stock · 67 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000424 · edgar.xml · derivative · entry 13

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners, L.P.

Disclosed balance after: 0

Underlying: Series B Preferred Stock · 1,665 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000424 · edgar.xml · derivative · entry 12

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners QP, L.P.

Disclosed balance after: 123,653

Underlying: Common Stock · 5,008 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000424 · edgar.xml · derivative · entry 11

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners QP, L.P.

Disclosed balance after: 0

Underlying: Series B Preferred Stock · 123,653 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000424 · edgar.xml · derivative · entry 10

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 2,931 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.exercise_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.expiration_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F5 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000424 · edgar.xml · derivative · entry 9

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners QP, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 217,816 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.exercise_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · derivative.expiration_date: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F5 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000424 · edgar.xml · derivative · entry 8

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 269 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.exercise_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.expiration_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F5 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000424 · edgar.xml · derivative · entry 7

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners QP, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 19,982 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.exercise_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · derivative.expiration_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

F5 · derivative.underlying_shares: Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.

SEC source: 0001192482-19-000424 · edgar.xml · nonDerivative · entry 6

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners QP, L.P.

Disclosed balance after: 498,606

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

SEC source: 0001192482-19-000424 · edgar.xml · nonDerivative · entry 5

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners QP, L.P.

Disclosed balance after: 280,790

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

SEC source: 0001192482-19-000424 · edgar.xml · nonDerivative · entry 4

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners, L.P.

Disclosed balance after: 15,875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

SEC source: 0001192482-19-000424 · edgar.xml · nonDerivative · entry 3

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By HighCape Partners, L.P.

Disclosed balance after: 12,944

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.

SEC source: 0001192482-19-000422 · edgar.xml · derivative · entry 6

Greenhalgh Ellis Skott · CIK 0001790671 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,976

Underlying: Common Stock · 80 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001192482-19-000422 · edgar.xml · derivative · entry 5

Greenhalgh Ellis Skott · CIK 0001790671 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series B Preferred Stock · 1,976 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.